154 related articles for article (PubMed ID: 17081563)
21. Genetic abnormalities in hereditary hemorrhagic telangiectasia.
Marchuk DA
Curr Opin Hematol; 1998 Sep; 5(5):332-8. PubMed ID: 9776212
[TBL] [Abstract][Full Text] [Related]
22. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
Kuehl HK; Caselitz M; Hasenkamp S; Wagner S; El-Harith el-HA; Manns MP; Stuhrmann M
Hum Mutat; 2005 Mar; 25(3):320. PubMed ID: 15712270
[TBL] [Abstract][Full Text] [Related]
23. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.
Bourdeau A; Faughnan ME; McDonald ML; Paterson AD; Wanless IR; Letarte M
Am J Pathol; 2001 Jun; 158(6):2011-20. PubMed ID: 11395379
[TBL] [Abstract][Full Text] [Related]
24. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
Lebrin F; Mummery CL
Trends Cardiovasc Med; 2008 Jan; 18(1):25-32. PubMed ID: 18206806
[TBL] [Abstract][Full Text] [Related]
25. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function.
Paquet ME; Pece-Barbara N; Vera S; Cymerman U; Karabegovic A; Shovlin C; Letarte M
Hum Mol Genet; 2001 Jun; 10(13):1347-57. PubMed ID: 11440987
[TBL] [Abstract][Full Text] [Related]
26. Characterization of chicken endoglin, a member of the zona pellucida family of proteins, and its tissue expression.
Rossi E; Langa C; Gilsanz A; Blanco FJ; Ayllón J; Villar E; Botella LM; Cabañas C; Shaw M; Bernabeu C
Gene; 2012 Jan; 491(1):31-9. PubMed ID: 21982971
[TBL] [Abstract][Full Text] [Related]
27. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
[TBL] [Abstract][Full Text] [Related]
28. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex.
Blanco FJ; Santibanez JF; Guerrero-Esteo M; Langa C; Vary CP; Bernabeu C
J Cell Physiol; 2005 Aug; 204(2):574-84. PubMed ID: 15702480
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional characterization of soluble endoglin receptor.
Van Le B; Franke D; Svergun DI; Han T; Hwang HY; Kim KK
Biochem Biophys Res Commun; 2009 Jun; 383(4):386-91. PubMed ID: 19268655
[TBL] [Abstract][Full Text] [Related]
30. Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors.
Koleva RI; Conley BA; Romero D; Riley KS; Marto JA; Lux A; Vary CP
J Biol Chem; 2006 Sep; 281(35):25110-23. PubMed ID: 16785228
[TBL] [Abstract][Full Text] [Related]
31. Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms.
Lux A; Gallione CJ; Marchuk DA
Hum Mol Genet; 2000 Mar; 9(5):745-55. PubMed ID: 10749981
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
[TBL] [Abstract][Full Text] [Related]
33. Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia.
Cymerman U; Vera S; Karabegovic A; Abdalla S; Letarte M
Hum Mutat; 2003 May; 21(5):482-92. PubMed ID: 12673790
[TBL] [Abstract][Full Text] [Related]
34. Endoglin in angiogenesis and vascular diseases.
ten Dijke P; Goumans MJ; Pardali E
Angiogenesis; 2008; 11(1):79-89. PubMed ID: 18283546
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.
Wehner LE; Folz BJ; Argyriou L; Twelkemeyer S; Teske U; Geisthoff UW; Werner JA; Engel W; Nayernia K
Clin Genet; 2006 Mar; 69(3):239-45. PubMed ID: 16542389
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of a family with hereditary hemorrhagic telangiectasia associated with hepatic arteriovenous malformation.
Lin WD; Wu JY; Hsu HB; Tsai FJ; Lee CC; Tsai CH
J Formos Med Assoc; 2001 Dec; 100(12):817-9. PubMed ID: 11802521
[TBL] [Abstract][Full Text] [Related]
38. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.
Bourdeau A; Cymerman U; Paquet ME; Meschino W; McKinnon WC; Guttmacher AE; Becker L; Letarte M
Am J Pathol; 2000 Mar; 156(3):911-23. PubMed ID: 10702408
[TBL] [Abstract][Full Text] [Related]
39. Investigation of endoglin wild-type and missense mutant protein heterodimerisation using fluorescence microscopy based IF, BiFC and FRET analyses.
Förg T; Hafner M; Lux A
PLoS One; 2014; 9(7):e102998. PubMed ID: 25080347
[TBL] [Abstract][Full Text] [Related]
40. Endoglin regulates mural cell adhesion in the circulatory system.
Rossi E; Smadja DM; Boscolo E; Langa C; Arevalo MA; Pericacho M; Gamella-Pozuelo L; Kauskot A; Botella LM; Gaussem P; Bischoff J; Lopez-Novoa JM; Bernabeu C
Cell Mol Life Sci; 2016 Apr; 73(8):1715-39. PubMed ID: 26646071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
